Results 161 to 170 of about 694,507 (206)
Some of the next articles are maybe not open access.
Breast Cancer Research and Treatment, 1996
Pseudomonas exotoxin has been genetically modified so that it targets cancer cells. This was accomplished by deleting its cell binding domain and replacing it with Fv fragments of antibodies that react with breast, colon, and other cancers. Several recombinant immunotoxins are now in clinical trials.
I, Pastan +3 more
openaire +2 more sources
Pseudomonas exotoxin has been genetically modified so that it targets cancer cells. This was accomplished by deleting its cell binding domain and replacing it with Fv fragments of antibodies that react with breast, colon, and other cancers. Several recombinant immunotoxins are now in clinical trials.
I, Pastan +3 more
openaire +2 more sources
BJOG: An International Journal of Obstetrics & Gynaecology, 1999
C J, Hayden, A H, Balen, A J, Rutherford
openaire +2 more sources
C J, Hayden, A H, Balen, A J, Rutherford
openaire +2 more sources
Recombination of repeat elements generates somatic complexity in human genomes
Cell, 2022Chung-Chau Hon, Joachim Luginbuhl
exaly
RNA transcripts stimulate homologous recombination by forming DR-loops
Nature, 2021Jiamin Zhang, Esther Rheinbay, Li Lan
exaly
Recombination between heterologous human acrocentric chromosomes
Nature, 2023Leonardo de Lima +2 more
exaly
Recombination | Homologous Recombination in Meiosis
2021Nancy M. Hollingsworth, Hani Zaher
openaire +1 more source